Biomea Fusion, Inc. BMEA
0.62 USD -0.04 (-5.47%)
At closeNov 3, 2026, 5:08 PM EST
0.66 +0.04 +6.28%
After hours · Nov 3, 5:08 PM ET
0.6238 Day range 0.6877
0.552 52-week range 2.24
- YTD
- -49.69%
- 1 year
- -52.74%
Analyst view
Consensus: buy
Buy
Price target (mean) 40.56 +6401.4% upside
Now 0.6238
- Target (low)
- 11.00
- Target (mean)
- 40.56
- Target (high)
- 128.00
Ratings (0m) 9 7 buy · 2 hold · 0 sell
- Strong buy3
- Buy4
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 9
- 1 month ago 9
- 2 months ago 10
- 3 months ago 9
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.92933 | -1.20 – -0.77 | -0.98 | +5.2% | 0 | 0.0% | 6 |
| Next quarter | -0.78 | -0.78 – -0.78 | -0.98 | +20.4% | 0 | 0.0% | 1 |
| Current year | -3.88 | -4.23 – -3.48 | -3.44 | -12.7% | 0 | 0.0% | 6 |
| Next year | -3.05 | -3.85 – -0.89 | -3.88 | +21.4% | 2.14M | 0.0% | 6 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 19, 2024 | D. Boral Capital | Maintained | Buy | Buy |
| Dec 18, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 17, 2024 | D. Boral Capital | Maintained | Buy | Buy |
| Dec 16, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 10, 2024 | D. Boral Capital | Maintained | Buy | Buy |
| Dec 10, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 21, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 19, 2024 | D. Boral Capital | Maintained | Buy | Buy |
| Oct 31, 2024 | Piper Sandler | Maintained | Overweight | Overweight |
| Oct 31, 2024 | EF Hutton | Maintained | Buy | Buy |
| Oct 31, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 30, 2024 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Oct 30, 2024 | EF Hutton | Maintained | Buy | Buy |
| Oct 22, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 9, 2024 | EF Hutton | Initiated | — | Buy |
| Sep 27, 2024 | Scotiabank | Maintained | Sector Outperform | Sector Outperform |
| Sep 27, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 27, 2024 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Sep 27, 2024 | Truist Securities | Upgrade | Hold | Buy |
| Sep 26, 2024 | Rodman & Renshaw | Upgrade | Neutral | Buy |
| Aug 29, 2024 | Capital One | Initiated | — | Overweight |
| Aug 27, 2024 | Citigroup | Maintained | Buy | Buy |
| Aug 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 25, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 11, 2024 | Truist Securities | Downgrade | Buy | Hold |
| Jun 7, 2024 | Citigroup | Maintained | Buy | Buy |
| Jun 7, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jun 7, 2024 | Piper Sandler | Maintained | Overweight | Overweight |
| Jun 7, 2024 | Barclays | Downgrade | Overweight | Equal-Weight |
| Jun 7, 2024 | Scotiabank | Maintained | Sector Outperform | Sector Outperform |